,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2016-09-16 04:13:00,"Few dispute that dividend growth investing is back en vogue, but not everyone seems to know exactly why dividend investing is one of the most well-documented ways to beat the market when deftly executed.",0.275371253490448,0.02912532538175583,0.6955033540725708,neutral,0.24624592065811157
1,2016-09-16 04:13:00,"So, why does dividend growth investing garner so much respect among seasoned investors?",0.3760966658592224,0.01142947468906641,0.6124739050865173,neutral,0.3646671772003174
2,2016-09-16 04:13:00,"Perhaps it seems obvious, but dividend growth investing is beloved because it flat-out works -- especially when dividends are reinvested to buy additional shares.",0.2864812910556793,0.013303671032190323,0.7002149820327759,neutral,0.2731776237487793
3,2016-09-16 04:13:00,"As just one of the many examples, a study from asset manager BlackRock found that a selected basket of dividend growth stocks outperformed an equally weighted basket of all stocks by roughly 30% from 1979 through 2004.",0.8816418647766113,0.07481879740953445,0.043539341539144516,positive,0.8068230748176575
4,2016-09-16 04:13:00,"Especially when combined with a strategy to reinvest all dividend payments to buy more shares, the results can be truly astounding, while requiring little additional time.",0.8909827470779419,0.016843292862176895,0.09217395633459091,positive,0.8741394281387329
5,2016-09-16 04:13:00,Here's a quick snapshot of a few of what I see as the best long-term dividend stocks on the market today.,0.13800466060638428,0.008493918925523758,0.8535014390945435,neutral,0.12951074540615082
6,2016-09-16 04:13:00,What makes these long-term dividend stocks so special?,0.06224798783659935,0.008434661664068699,0.9293174147605896,neutral,0.053813327103853226
7,2016-09-16 04:13:00,"For starters, each has an enviable track record of growing their dividend payments each year.",0.8966472148895264,0.013809094205498695,0.08954371511936188,positive,0.8828381299972534
8,2016-09-16 04:13:00,"If our strategy is to beat the market by buying great dividend growth stocks and reinvesting their proceeds, these seem like relatively safe bets based on the multidecade history of annual dividend increases alone.",0.5072978734970093,0.015784215182065964,0.4769178628921509,positive,0.4915136694908142
9,2016-09-16 04:13:00,"However, the sectors in which the above names operate -- consumer staples and healthcare -- also provide a stable foundation for continued success for many years to come.",0.4831421375274658,0.010521350428462029,0.506336510181427,neutral,0.47262078523635864
10,2016-09-16 04:13:00,"The aging Baby Boomer population should serve as a long-term tailwind for the entire healthcare sector, and Johnson & Johnson 's(NYSE: JNJ) formidable competitive position within the industry makes it a fantastic option for long-term dividend investors.",0.9007059931755066,0.017099037766456604,0.08219496160745621,positive,0.8836069703102112
11,2016-09-16 04:13:00,"All three of J&J's core business segments -- consumer, medical devices, and pharmaceutical -- are all relatively stable, producing consistent revenues and profits from which it can fund its dividend.",0.8587755560874939,0.01483161747455597,0.12639276683330536,positive,0.8439439535140991
12,2016-09-16 04:13:00,"The pharmaceutical segment continues to act as the straw that stirs J&J's financial drink, accounting for the greatest percentage of the company's sales and profits.",0.24727241694927216,0.01859939657151699,0.7341281771659851,neutral,0.2286730259656906
13,2016-09-16 04:13:00,"It is also the fastest-growing segment in Johnson & Johnson's business, increasing nearly 9% in the company's most recent quarter versus a 0.8% increase in medical devices and a 1.8% decline in consumer sales.",0.9400672316551208,0.016061915084719658,0.043870922178030014,positive,0.9240053296089172
14,2016-09-16 04:13:00,"Segment-specific vicissitudes aside, Johnson & Johnson remains a hugely profitable enterprise by virtually any metric.",0.7969775795936584,0.012202870100736618,0.19081953167915344,positive,0.7847747206687927
15,2016-09-16 04:13:00,"Its 56% dividend payout ratio seems sustainable for a business of its size, profitability, and capex requirements.",0.7911883592605591,0.013242002576589584,0.19556960463523865,positive,0.7779463529586792
16,2016-09-16 04:13:00,"Trading at around 22 times its past-12-months' earnings values, the company's stock is below that of the overall market, which also doesn't seem particularly out of line for a company of its quality and maturity.",0.019267044961452484,0.9208822846412659,0.059850629419088364,negative,-0.9016152620315552
17,2016-09-16 04:13:00,"At the end of the day, Johnson & Johnson remains a fantastic option for investors looking to fund their retirements through long-term dividend investing.",0.42434850335121155,0.021121544763445854,0.5545299649238586,neutral,0.40322697162628174
18,2016-09-16 04:13:00,"Much like Johnson & Johnson above, Abbott Labs '(NYSE: ABT) place as a diversified healthcare products company makes it a dividend dynamo capable of standing the test of time.",0.8585322499275208,0.012909517623484135,0.1285582184791565,positive,0.845622718334198
19,2016-09-16 04:13:00,"After spinning out its biotech business into the publicly traded AbbVie in 2013, Abbott Labs appears focused and ready to seize the considerable opportunities provided by its market.",0.8860480189323425,0.014111506752669811,0.09984049201011658,positive,0.8719365000724792
20,2016-09-16 04:13:00,"In the company's most recently reported quarter, three of Abbot Labs' four reporting segments produced sales growth in the mid to high single digits, and its nutrition segment -- the long ""disappointment"" in the report -- still saw sales rise 4.3%.",0.9496918320655823,0.020205281674861908,0.03010287508368492,positive,0.9294865727424622
21,2016-09-16 04:13:00,"Like many large U.S. multinationals, the outsized strength of the U.S. dollar has served as a moderate headwind to Abbott's results, though the company remains quite profitable all the same.",0.1122942641377449,0.8406742811203003,0.04703148081898689,negative,-0.728380024433136
22,2016-09-16 04:13:00,"Furthermore, analysts see Abbott Labs producing double-digit profit growth in each of the next two full fiscal years, making its valuation discount relative to its peers seem likely to disappear if the company continues to execute.",0.9135829210281372,0.05023193359375,0.03618507832288742,positive,0.8633509874343872
23,2016-09-16 04:13:00,"Also like Johnson & Johnson, Abbott Labs' streak of 43 consecutive annual dividend increases make it a fairly safe bet that its continued dividend growth will proceed for years to come.",0.916122317314148,0.01487690582871437,0.0690007284283638,positive,0.9012454152107239
24,2016-09-16 04:13:00,"With a 2.5% current dividend yield and hugely favorable demographics to underpin its long-term growth, Abbott Labs also seems like a fantastic option for dividend investors today.",0.8335779309272766,0.014610150828957558,0.15181195735931396,positive,0.8189677596092224
25,2016-09-16 04:13:00,Though I could easily continue to sing the praises of the other healthcare name on the list above -- Medtronic -- I'll instead make the case for consumer staples powerhouse Procter & Gamble (NYSE: PG) as a slam-dunk long-term dividend growth play.,0.39645832777023315,0.015057507902383804,0.5884841680526733,neutral,0.38140082359313965
26,2016-09-16 04:13:00,"To see what makes P&G such a fantastic business, it helps to understand what has led its stock price to slightly underperform the market over the last two years.",0.6804435849189758,0.0691145807504654,0.2504417598247528,positive,0.6113290190696716
27,2016-09-16 04:13:00,"The company behind such well-known everyday brands including Tide, Bounty, Pampers, and many more has been hammered by negative foreign exchange impacts in recent quarters.",0.02070353738963604,0.9554136395454407,0.023882754147052765,negative,-0.9347100853919983
28,2016-09-16 04:13:00,"Procter & Gamble has also faced increased competition from a host in insurgent products that have adroitly leveraged the lower barriers to entry provided by technology; Dollar Shave Club's challenge to Gillette is perhaps the most obvious example, though others abound.",0.7662544846534729,0.043263476341962814,0.1904819756746292,positive,0.7229909896850586
29,2016-09-16 04:13:00,"For whatever reason, P&G's management had been slow to respond, though the company's more recent plan to reduce costs and reinvest in brand growth has been warmly received by analysts, which brings me to my overarching point in this investing thesis: P&G's ability to endure.",0.9121443033218384,0.022107308730483055,0.06574840843677521,positive,0.8900370001792908
30,2016-09-16 04:13:00,"As the largest consumer goods company in the world with leading market share across the bulk of its product segments, P&G's fortress-like competitive position should give it the ability to withstand and adapt to whatever changes will inevitably come its way.",0.90244060754776,0.012357071042060852,0.08520232141017914,positive,0.8900835514068604
31,2016-09-16 04:13:00,"The company is an institution, one that consistently produces robust profits come rain, snow, sleet, or shine.",0.8572232127189636,0.014280023984611034,0.12849684059619904,positive,0.8429431915283203
32,2016-09-16 04:13:00,"Some years will be better than others, but its leading brands and distribution virtually guarantee consumers will continue to use Procter & Gamble's products for generations to come.",0.8391841650009155,0.014365403912961483,0.14645038545131683,positive,0.8248187899589539
33,2016-09-16 04:13:00,The same holds true with P&G's cash dividends.,0.13800287246704102,0.009296231903135777,0.8527008891105652,neutral,0.12870663404464722
34,2016-09-16 04:13:00,Case in point: Procter & Gamble's amazing history of dividend growth dates back to the Eisenhower administration.,0.8468149900436401,0.013151817955076694,0.14003312587738037,positive,0.8336631655693054
35,2016-09-16 04:13:00,"Especially given its current 3% dividend, Procter & Gamble remains arguably the best dividend stock on the market for long-term payout growth.",0.9290374517440796,0.01721017248928547,0.053752295672893524,positive,0.9118272662162781
36,2016-09-16 04:13:00,"The world's biggest tech company forgot to show you something, but a few Wall Street analysts and the Fool didn't miss a beat: There's a small company that's powering their brand-new gadgets and the coming revolution in technology.",0.07462237030267715,0.16781271994113922,0.757564902305603,neutral,-0.09319034963846207
37,2016-09-16 04:13:00,"And we think its stock price has nearly unlimited room to run for early, in-the-know investors!",0.27356037497520447,0.013653220608830452,0.7127864360809326,neutral,0.25990715622901917
38,2016-09-16 04:13:00,"To be one of them, just click here .",0.08918054401874542,0.07975278049707413,0.8310666680335999,neutral,0.009427763521671295
39,2016-09-16 04:13:00,Andrew Tonner has no position in any stocks mentioned.,0.011034811846911907,0.05937652289867401,0.9295886754989624,neutral,-0.04834171012043953
40,2016-09-16 04:13:00,The Motley Fool owns shares of and recommends Johnson and Johnson.,0.03810666501522064,0.0159144327044487,0.9459789395332336,neutral,0.022192232310771942
41,2016-09-16 04:13:00,The Motley Fool owns shares of Medtronic.,0.024480517953634262,0.016628477722406387,0.9588910341262817,neutral,0.007852040231227875
42,2016-09-16 04:13:00,The Motley Fool recommends Kimberly-Clark and Procter and Gamble.,0.032223381102085114,0.02425115928053856,0.943525493144989,neutral,0.007972221821546555
43,2016-09-16 04:13:00,Try any of our Foolish newsletter services free for 30 days .,0.02325451746582985,0.013860778883099556,0.9628846645355225,neutral,0.009393738582730293
44,2016-09-16 04:13:00,"We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.",0.7942618727684021,0.015105843544006348,0.19063223898410797,positive,0.7791560292243958
45,2016-09-16 04:13:00,The Motley Fool has a disclosure policy .,0.016547100618481636,0.017303917557001114,0.9661489725112915,neutral,-0.0007568169385194778
46,2016-09-16 04:13:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.01563790813088417,0.9741575717926025,neutral,-0.005433341488242149
